Crocetin Enhances Temozolomide Efficacy in Glioblastoma Therapy Through Multiple Pathway Suppression - Tsai, Wei-En; Liu, Yen-Tsen; Kuo, Fu-Hsuan; Cheng, Wen-Yu; Shen, Chiung-Chyi; Chiao, Ming-Tsang; Huang, Yu-Fen; Liang, Yea-Jiuen; Yang, Yi-Chin; Hsieh, Wan-Yu; Chen, Jun-Peng; Liu, Szu-Yuan; et al. (Current neurovascular research, 2024)
Keywords: Antineoplastic Agents, Alkylating - pharmacology; Antineoplastic Agents, Alkylating - therapeutic use; Brain Neoplasms - drug therapy; Brain Neoplasms - pathology; Carotenoids - pharmacology; Carotenoids - therapeutic use; Cell Line, Tumor; Cell Movement - drug effects; Cell Proliferation - drug effects; Cell Survival - drug effects; Drug Synergism; Glioblastoma - drug therapy; Glioblastoma - pathology; Humans; Signal Transduction - drug effects; Temozolomide - pharmacology; Temozolomide - therapeutic use; Vitamin A - analogs & derivatives; temozolomide; cell migration; tumor growth; glioblastoma; AKT signaling; Crocetin